GlassScriptPhysician profile
Daksesh B Patel
NPI 1154526770
$744,811.95
in general payments reported to CMS, 2019-2025
49 companies · $200K in 2025
The $200K reported for 2025 was more than what 99% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $59K · 2021: $34K · 2022: $76K · 2023: $103K · 2024: $272K · 2025: $200K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $245K · Honoraria: $219K · Travel and Lodging: $83K · Food and Beverage: $26K · Consulting Fee: $1,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $245,265.00 |
| Honoraria | $218,816.50 |
| Travel and Lodging | $82,740.21 |
| Food and Beverage | $26,029.83 |
| Consulting Fee | $1,738.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $434,713.36 | 2019-2025 | Sucraid, Sucraid |
| Phathom Pharmaceuticals, INC. | $210,677.28 | 2024-2025 | Voquezna |
| Evoke Pharma, INC. | $74,200.17 | 2022-2025 | Gimoti |
| Medtronic, INC. | $10,072.95 | 2021-2024 | Gi Genius, Endoflip |
| Takeda Pharmaceuticals U.S.A., INC. | $2,537.95 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Redhill Biopharma INC. | $1,976.49 | 2020-2023 | Talicia, Movantik, Aemcolo |
| Ardelyx, INC. | $1,857.51 | 2022-2025 | Ibsrela |
| Abbvie INC. | $1,795.88 | 2019-2025 | |
| Genzyme Corporation | $970.47 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $840.53 | 2019-2025 | Xifaxan, Relistor |
| Endogastric Solutions, INC | $648.89 | 2019-2023 | Esophyx |
| Janssen Biotech, INC. | $581.19 | 2021-2025 | Tremfya, Stelara |
| Covidien LP | $543.22 | 2019-2020 | |
| Pfizer INC. | $356.68 | 2023-2025 | |
| Cook Medical LLC | $352.83 | 2020-2024 | Hemospray, Fusion |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $336.19 | 2019-2025 | |
| Lilly USA, LLC | $260.89 | 2024-2025 | Omvoh |
| Madrigal Pharmaceuticals | $190.28 | 2024-2025 | Rezdiffra, Resmetirom |
| Intercept Pharmaceuticals, INC. | $142.91 | 2022-2025 | Ocaliva |
| Braintree Laboratories, INC. | $142.60 | 2019-2022 | |
| Ambu INC. | $138.26 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $135.18 | 2024-2025 | Dupixent |
| Aimmune Therapeutics, INC. | $118.57 | 2025 | Zenpep |
| Celgene Corporation | $114.03 | 2021-2023 | Zeposia |
| Merit Medical Systems INC | $102.92 | 2025 | Esophyx, Endomaxx Stent and Delivery System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.74 | 2023-2024 | Cyltezo |
| Boston Scientific Corporation | $78.23 | 2022 | |
| Celltrion USA INC. | $76.26 | 2024-2025 | Vegzelma |
| Allergan, INC. | $70.34 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $64.71 | 2021-2024 | Dificid |
| Echosens North America, INC. | $62.48 | 2024-2025 | Fibroscan, Fibroscan |
| Ipsen Biopharmaceuticals, INC | $55.41 | 2024-2025 | Iqirvo, Bylvay |
| Romark Laboratories, Lc | $55.14 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $54.80 | 2022-2023 | Rebyota |
| Mirum Pharmaceuticals, INC. | $49.24 | 2024-2025 | Livmarli |
| Novo Nordisk INC | $43.26 | 2025 | Wegovy |
| Ucb, INC. | $42.58 | 2019 | |
| Daiichi Sankyo INC. | $39.09 | 2020 | |
| Ethicon US, LLC | $35.69 | 2019 | |
| Vivus LLC | $30.96 | 2021-2025 | Qsymia |
| Concordia Pharmaceuticals INC. | $24.20 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $23.37 | 2021-2024 | Forceps |
| Biocon Biologics INC | $20.55 | 2025 | Yesintek |
| Nestle Healthcare Nutrition INC. | $17.53 | 2022 | |
| Dentsply Ih Ab | $16.51 | 2024 | Navina Rectal Catheter Set Regular |
| Napo Pharmaceuticals INC | $14.99 | 2021 | |
| Capsovision, INC. | $14.17 | 2023 | Capsocam Plus |
| W. L. Gore & Associates, INC. | $13.47 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$400.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$52,121.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daksesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.